BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,021.63
0.57%
US Tech 100
20,372.40
0.00%
Dow Jones
44,860.31
0.28%
Brent Oil
72.57
0.17%
Bitcoin
93,446.50
1.60%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Ipsen SA (IPN) Quote

Ipsen SA

Ipsen SA (IPN)

EU
109.00
-0.50
( -0.46% )
Updated: 03:26:03
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
109.00
Bid
108.90
Ask
109.10
Volume
2,189
109.00 Day's Range 109.60
99.70 52 Week Range 126.70
Market Cap
8.941B
Previous Close
109.50
Open
109.60
Last Trade
5
@
109
Last Trade Time
03:26:03
Financial Volume
-
VWAP
-
Average Volume (3m)
63,003
Shares Outstanding
82,029,421
Dividend Yield
1.10%
PE Ratio
13.94
Earnings Per Share (EPS)
7.86
Revenue
3.37B
Net Profit
644.4M

About Ipsen SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ipsen.com
Headquarters
Boulogne-billancourt, Hauts-de-seine, Fra
Founded
-
Ipsen SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker IPN. The last closing price for Ipsen was 109.50 €. Over the last year, Ipsen shares have traded in a share price range of 99.70 € to 126.70 €.

Ipsen currently has 82,029,421 shares outstanding. The market capitalization of Ipsen is 8.98 € billion. Ipsen has a price to earnings ratio (PE ratio) of 13.94.

Ask ADVFN Intelligence (AI)

IPN Latest News

More News

Bylvay® (odévixibat) montre une amélioration soutenue en termes de sévérité des démangeaisons et de taux d’acides biliaires sériques chez les patients atteints de CIFP et du SAG

Bylvay® (odévixibat) montre une amélioration soutenue en termes de sévérité des démangeaisons et de taux d’acides biliaires sériques chez les patients atteints de CIFP et du SAG Ipsen met en avant...

November 18 2024
UK Regulatory

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS Ipsen presents 3 late-breaking presentations and 8 abstracts across...

November 18 2024
UK Regulatory

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024 PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: IPSEY) today...

November 18 2024
GlobeNewswire Inc.

Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus

Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus Ipsen presents 3 late-breaking presentations and 8 abstracts...

November 15 2024
UK Regulatory

Iqirvo® (elafibranor) montre des données d’efficacité et de tolérance sur une période allant jusqu’à trois ans chez les patients atteints de CBP avec une amélioration de la fatigue et du prurit

Iqirvo® (elafibranor) montre des données d’efficacité et de tolérance sur une période allant jusqu’à trois ans chez les patients atteints de CBP avec une amélioration de la fatigue et du prurit...

November 15 2024
UK Regulatory

Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September...

November 15 2024
GlobeNewswire Inc.

Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de...

November 07 2024
UK Regulatory

Ipsen - October 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - October 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights...

November 07 2024
UK Regulatory

Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance

Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance PARIS, FRANCE, 23 October 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global...

October 23 2024
UK Regulatory

Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance

PARIS, FRANCE, 23 October 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its performance for the year to date and the third quarter of...

October 23 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
110.925925925926108111.5106.978535110.09899127DE
4-3.9-3.45438441098112.9113.8105.564841110.14607634DE
121.41.30111524164107.6117.5104.663003110.97702504DE
26-14.2-11.525974026123.2126.7100.368018111.89082876DE
524.84.60652591171104.2126.799.771423109.69865057DE
15620.2222.775399864888.78130.77780664104.24617573DE
2605.75.5179090029103.3130.734.210298788.80923873DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALNEVNeovacs
0.0002 €
(100.00%)
1.25M
ATOAtos SE
0.765 €
(35.93%)
6.68M
LBIRDLumibird
9.28 €
(28.53%)
53.81k
ALGAUGaussin
0.0488 €
(16.19%)
133.17k
DBVDBV Technologies
0.697 €
(16.17%)
578.72k
BIDSGascogne DS
0.0008 €
(-63.64%)
44.92k
EMGDSEuromedis DS
0.0006 €
(-25.00%)
10.03k
ALACTActicor Biotech
0.25 €
(-13.79%)
17.88k
ALSAFSAFE
0.0822 €
(-10.65%)
31.5k
ALAGRAGROGENERATION
0.042 €
(-8.30%)
7.53k
BCPBanco Comercial Portugues SA
0.4407 €
(-0.97%)
12.46M
ALDRVDrone Volt
0.0037 €
(5.71%)
11.79M
ATOAtos SE
0.765 €
(35.93%)
6.68M
ALTDTonner Drones
0.01 €
(-1.96%)
1.85M
ALNRGEnergisme SA
0.0057 €
(0.00%)
1.85M

Discussion

View Full Feed
DiamondHealer95 DiamondHealer95 6 minutes ago
OH HERE IT IS! THE RANDOM "THE PRICE SHOULD BE" POST!

Definitely listen to this poster! They know what they're talking about!

💩
KBLB
edbi46 edbi46 6 minutes ago
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!! HEHEHE.

ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY INFLUENCE
MCF WBA
Viking61 Viking61 18 minutes ago
It also states that we have a chance to fix it the right way. GLTA
FNMA
stocksrising stocksrising 18 minutes ago
Ahhh, the good ole’ days when we could all talk about the benefits of Daxxy vs. competition ( and the claims and marketing on social media) …if deal closes, all a moot point, but if not, Revance could really take advantage of others missteps( assuming new leadership @ helm)

https://w
RVNC
NioTurd NioTurd 21 minutes ago
Let's play game... How much % lower are we going today?
I start : -4% (sarcastic)
NB
DMC8 DMC8 23 minutes ago
API supply orders as of Oct 04, 2024.
https://www.seair.co.in/us-import/i-amarin-pharma.aspx
API
Seminole Red Seminole Red 28 minutes ago
Biden Administration Awards $6.6 Billion Loan to EV Maker Accused of Defrauding Investors

“This $6 billion taxpayer-backed loan to Rivian is a glaring example of corporate welfare disguised as clean energy investment,” said American Energy Institute CEO Jason Isaac.

htt
fuagf fuagf 32 minutes ago
OMOLIVES, Now post some of Boebert's best, Jewish space
lasers was one? And MTG. That of yours was very weak.
Jimmy Joe Jimmy Joe 32 minutes ago
Awwwwww poor Bubbles. LMAO~!

Is Elite doing too well for ya~?

🩳y
ELTP
fuagf fuagf 38 minutes ago
dbergh, Doesn't surprise at all you would have downplayed it as Trump
did. You likely may have suggested trying drinking disinfectant too.
fuagf fuagf 48 minutes ago
OMOLIVES, Still you used it. To the bits you picked there. The first

"Start with Mitch McConnell and Senate Republicans in 2021. They could — and should — have voted to convict Trump after his second impeachment, which would have prevented him from running again for the presidency
Bob Mullet Bob Mullet 51 minutes ago
Your opinions are garbage 
Still spamming the board?
People laugh at you 
Keep it up!!👍🏻 
KBLB
Truth_is_a_tool Truth_is_a_tool 55 minutes ago
“” quit spamming the board “
She thinks she’s accomplishing a profound feat with her googling 🤣🤣🤣.
KBLB
worthylion worthylion 1 hour ago
FTCO Been sliding lately as gold has declined a little despite 9%+ dividend yield. IMO Trump's presidency likely to be inflationary and create market uncertainty. A market "risk on" reaction to his election could turn into "risk off" after inauguration and increase the risk of an overdue correction.
FTCO
Steady_T Steady_T 1 hour ago
Maybe. I'd rather see them spend their efforts on getting the NDA finished.

Having said that, there are a number of trials that I'd like to see get underway with Parkinson's being one of them.
AVXL
newflow newflow 1 hour ago
lota WMI as a creditor has any claims against R?. Who is representing WMI as a creditor to R?.
COOP
Maximilliano Maximilliano 1 hour ago
Trump's announcement said the council "will consist of all Departments and Agencies involved in the permitting, production, generation, distribution, regulation, transportation, of ALL forms of American Energy."

https://www.axios.com/2024/11/26/trump-ai-czar-role-elon-musk
FCEL
Buellersback Buellersback 1 hour ago
You most certainly are. It's very obvious and kind of disgusting. You are the reason this chat turned into a sh## show and everyone here knows it. The rest of the clowns joined in once you started the 'I'm just here for cheap entertainment" parade.
RGLG
thistraderknowsall thistraderknowsall 1 hour ago
ZENA wakeup call for the shorts! $20 to $50 is next target ! Enjoy your margin covering !!
longago longago 1 hour ago
Their PR is abysmal that is for damn sure.

If Ron does not at least glance at the comments here he is not learning anything.

Next week after Thanksgiving and after Q1 has ended I am going to try to engage him in a reasonable email conversation about some of the issues
RJDG
Ricorich Ricorich 1 hour ago
style="font-size: 1.5em"AgEagle Aerial Systems Invited to the White House for Key Discussions on Commercial Unmanned Aerial Vehicles (UAVs)

https://ageagle.com/ageagle-aerial-systems-invited-to-the-white-house-for-key-discussions-on-commercial-unm
UAVS
Wolf-man jack Wolf-man jack 1 hour ago
WQLF SAYS ; CVSI is still plugging along with three AcQisitions and more to come before CVSI gets AcQuired YQU WILL Then Understand YQU Understand. Have Mercy Have Faith Have Patience Have International Partners and M&A’s WQLF Ahooooooo

Gimminy Cricket 🦗 Said;

CVSI

Your Recent History

EU
IPN
Ipsen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21